Impairment of the Ubiquitin-Proteasome System by Protein Aggregation

American Association for the Advancement of Science (AAAS) - Tập 292 Số 5521 - Trang 1552-1555 - 2001
Neil Bence1, Roopal M. Sampat1, Ron R. Kopito1
1Department of Biological Sciences, Stanford University, Stanford, CA 94305–5020, USA.

Tóm tắt

Intracellular deposition of aggregated and ubiquitylated proteins is a prominent cytopathological feature of most neurodegenerative disorders. Whether protein aggregates themselves are pathogenic or are the consequence of an underlying molecular lesion is unclear. Here, we report that protein aggregation directly impaired the function of the ubiquitin-proteasome system. Transient expression of two unrelated aggregation-prone proteins, a huntingtin fragment containing a pathogenic polyglutamine repeat and a folding mutant of cystic fibrosis transmembrane conductance regulator, caused nearly complete inhibition of the ubiquitin-proteasome system. Because of the central role of ubiquitin-dependent proteolysis in regulating fundamental cellular events such as cell division and apoptosis, our data suggest a potential mechanism linking protein aggregation to cellular disregulation and cell death.

Từ khóa


Tài liệu tham khảo

Ciechanover A., Orian A., Schwartz A. L., Bioessays 22, 442 (2000).

Mayer R. J., Lowe J., Lennox G., Doherty F., Landon M., Prog. Clin. Biol. Res. 317, 809 (1989).

C. J. Cummings et al. Neuron 24 879 (1999).

P. Fernandez-Funez et al. Nature 408 101 (2000).

T. Kitada et al. Nature 392 605. (1998).

K. Saigoh et al. Nature Genet. 23 47 (1999).

E. Leroy et al. Nature 395 451 (1998).

Gilon T., Chomsky O., Kulka R. G., EMBO J. 17, 2759 (1998).

The GFP u plasmid was created by ligating an oligonucleotide encoding ACKNWFSSLSHFVIHL into the GFP-C1 plasmid (Clontech).

Cells were labeled with 35 S-Met and 35 S-Cys for 10 min chased and lysed by sonication in phosphate-buffered saline containing 1% Triton X-100. Lysates were immunoprecipitated with antibody to GFP (anti-GFP) and resolved by SDS–polyacrylamide gel electrophoresis (SDS-PAGE). For immunoblotting cells were lysed in 10 mM tris (pH 7.4) 5 mM EDTA with 1% Triton X-100.

Clasto-lactacystin β-lactone the active form of lactacystin was used in this study.

For GFP u -1 characterization 10 000 to 15 000 cells were analyzed on a flow cytometer.

The chymotrypsin-like peptidase activity of the proteasome was assayed with the fluorogenic substrate succinyl-Leu-Leu-Val-Tyr-AMC. Cells were treated with the irreversble inhibitor lactacystin washed lysed in buffer containing 10 mM tris (pH 7.5) 1 mM EDTA 20% glycerol 2 mM adenosine 5′-triphosphate 0.5% Triton X-100 and protease inhibitors [50 μM phenylmethylsulfonyl fluoride 50 μM TPCK (tosyl phenylalanyl chloromethylketone) 2 μg/ml aprotinin and 2 μg/ml leupeptin] and incubated with 1 mM substrate at room temperature for 3 hours.

10.1152/physrev.1999.79.1.S167

10.1083/jcb.143.7.1883

The FLAG-ΔF508 construct was generated from FLAG-CFTR (33).

10.1146/annurev.neuro.23.1.217

10.1073/pnas.91.12.5355

For analysis of ubiquitin conjugates ∼200 000 cells collected by fluorescence-activated cell sorting (FACS) from the top 10% and lowest 10% of cells expressing Q25-GFP and Q103-GFP were lysed in SDS sample buffer and resolved by SDS-PAGE.

Finley D., Ciechanover A., Varshavsky A., Cell 37, 43 (1984).

Sherwood S. W., Kung A. L., Roitelman J., Simoni R. D., Schimke R. T., Proc. Natl. Acad. Sci. U.S.A. 90, 3353 (1993).

Wojcik C., Schroeter D., Stoehr M., Wilk S., Paweletz N., Eur. J. Cell Biol. 70, 172 (1996).

For cell cycle analyses HEK 293 cells were fixed in 4% paraformaldehyde 72 hours after transfection and treated with 5 μg/ml ribonuclease A for 2 hours at room temperature stained with 10 μg/ml propidium iodide and analyzed for DNA and GFP content by flow cytometry.

Schulz J. B., Dichgans J., Curr. Opin. Neurol. 12, 433 (1999).

Overexpression of GFP u itself a short-lived protein does not cause cell cycle arrest indicating that the observed increase is not due simply to the presence of an abundant UPS substrate.

B. Bercovich et al. J. Biol. Chem. 272 9002 (1997).

Akopian T. N., Kisselev A. F., Goldberg A. L., J. Biol. Chem. 272, 1791 (1997).

Kwak S., Masaki T., Ishiura S., Sugita H., Neurosci. Lett. 128, 21 (1991).

C. J. Cummings et al. Nature Genet. 19 148 (1998).

W. C. Wigley et al. J. Cell Biol. 145 481 (1999).

Garcia-Mata R., Bebok Z., Sorscher E. J., Sztul E. S., J. Cell Biol. 146, 1239 (1999).

Raina A. K., Zhu X., Monteiro M., Takeda A., Smith M. A., Prog. Cell Cycle Res. 4, 235 (2000).

Howard M., et al., Am. J. Physiol. 269, C1565 (1995).

We thank R. Frizzell for FLAG-CFTR A. Tobin for huntingtin plasmids M. Bucci for the GFP cell line M. Rexach for anti-GFP and C. Carswell-Crumpton for assistance with flow cytometry. We also thank R. Rajan and other members of the Kopito laboratory for stimulating discussions. Supported in part by a research grant from the National Institutes of Health a Howard Hughes Summer Fellowship from the Department of Biological Sciences at Stanford University and an NIH predoctoral training grant.